| human | Q5 |
| P27 | country of citizenship | Italy | Q38 |
| P734 | family name | Gargiulo | Q21492278 |
| Gargiulo | Q21492278 | ||
| Gargiulo | Q21492278 | ||
| P735 | given name | Giuseppe | Q15720844 |
| Giuseppe | Q15720844 | ||
| P1412 | languages spoken, written or signed | French | Q150 |
| Italian | Q652 | ||
| English | Q1860 | ||
| P106 | occupation | University of Naples Federico II | Q691851 |
| P21 | sex or gender | male | Q6581097 |
| Q48912264 | A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More? |
| Q41094165 | A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation |
| Q88737406 | Activated Clotting Time During Unfractionated Heparin-Supported Coronary Intervention: Is Access Site the New Piece of the Puzzle? |
| Q47862169 | Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX. |
| Q50043470 | Akap1 Regulates Vascular Function and Endothelial Cells Behavior |
| Q46093469 | Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry |
| Q47159836 | Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle. |
| Q38962486 | Antithrombotic therapy in TAVI patients: changing concepts. |
| Q90325330 | Antithrombotic treatment strategies after PCI - Authors' reply |
| Q84082937 | Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: a clinical case report |
| Q51695615 | Bivalirudin in Current Practice: Melius Abundare Quam Deficere? |
| Q88070838 | Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes |
| Q86880621 | Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials |
| Q37864877 | Cardiovascular effects of treadmill exercise in physiological and pathological preclinical settings |
| Q30854056 | Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: a meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion. |
| Q51673331 | Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation. |
| Q46060844 | Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry |
| Q42430441 | Correction: Akap1 Deficiency Promotes Mitochondrial Aberrations and Exacerbates Cardiac Injury Following Permanent Coronary Ligation via Enhanced Mitophagy and Apoptosis |
| Q57764113 | Cyphering the Mechanism of Late Failure of Bioresorbable Vascular Scaffolds in Percutaneous Coronary Intervention of the Left Main Coronary Artery |
| Q61400770 | DAPT Duration After Drug-Eluting Stent Implantation |
| Q61400778 | Deciding on the Duration of Dual Antiplatelet Therapy—When the Choice Between 2 Evils Is Still Evil |
| Q61401174 | Department of Error |
| Q40809602 | Dermcidin: a skeletal muscle myokine modulating cardiomyocyte survival and infarct size after coronary artery ligation. |
| Q38708145 | Developing drugs for use before, during and soon after percutaneous coronary intervention. |
| Q37586414 | Diabetes does not impact the diagnostic performance of contrast-based fractional flow reserve: insights from the CONTRAST study |
| Q90213322 | Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis |
| Q45197667 | EGFR trans-activation by urotensin II receptor is mediated by β-arrestin recruitment and confers cardioprotection in pressure overload-induced cardiac hypertrophy. |
| Q40833461 | Early discharge after transfemoral transcatheter aortic valve implantation |
| Q48657324 | Early results of MitraClip system implantation by real-time three-dimensional speckle-tracking left ventricle analysis. |
| Q93159674 | Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial |
| Q88631939 | Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study |
| Q39586952 | Effects of successful percutaneous lower extremity revascularization on cardiovascular outcome in patients with peripheral arterial disease |
| Q60196982 | Embolic protection devices during carotid artery stenting: Is there a difference between proximal occlusion and distal filter? |
| Q34486136 | Endovascular treatment of lower extremity arteries is associated with an improved outcome in diabetic patients affected by intermittent claudication. |
| Q57764124 | Five-year outcomes of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with left main coronary artery disease: An updated meta-analysis of randomized trials and adjusted observational studies |
| Q36974257 | Genetic deletion of uncoupling protein 3 exaggerates apoptotic cell death in the ischemic heart leading to heart failure. |
| Q50094276 | Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis. |
| Q47208384 | Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial |
| Q57189340 | Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates |
| Q61400836 | Impact of chronic kidney disease on 2-year clinical outcomes in patients treated with 6-month or 24-month DAPT duration: An analysis from the PRODIGY trial |
| Q57764132 | Impact of moderate preoperative chronic kidney disease on mortality after transcatheter aortic valve implantation |
| Q39044549 | Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5,971 patients. |
| Q39904581 | Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial. |
| Q40116423 | Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention |
| Q60196992 | Increased mortality after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis and low ejection fraction: A meta-analysis of 6898 patients |
| Q53361030 | Induction of mitogen-activated protein kinases is proportional to the amount of pressure overload. |
| Q57764071 | Is the Metallic Stent a Safe Treatment for Bioresorbable Scaffold Failure? |
| Q61400858 | Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial |
| Q39093174 | Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease. |
| Q42333629 | Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention |
| Q53713231 | Management issues of chronic therapy with non-vitamin K oral anticoagulants or antiplatelet agents: Different or alike? |
| Q51699985 | Meta-Analyses of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: Do Bleeding and Stent Thrombosis Weigh Similar on Mortality? |
| Q39191699 | Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation |
| Q38236970 | Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis. |
| Q38344419 | Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients |
| Q35643622 | New cerebral lesions at magnetic resonance imaging after carotid artery stenting versus endarterectomy: an updated meta-analysis |
| Q57764156 | New-Onset Coronary Aneurism and Late-Acquired Incomplete Scaffold Apposition After Full Polymer Jacket of a Chronic Total Occlusion With Bioresorbable Scaffolds |
| Q57764078 | New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association? |
| Q57764160 | One-Year Coverage by Optical Coherence Tomography of a Bioresorbable Scaffold Neocarina: Is It Safe to Discontinue Dual-Antiplatelet Therapy? |
| Q39690599 | One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice |
| Q50266833 | Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney Disease |
| Q44059286 | Prevalence and characteristics of true and apparent treatment resistant hypertension in the Campania Salute Network. |
| Q50645391 | Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients. |
| Q38386268 | Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial |
| Q38820488 | Renal dysfunction and transcatheter aortic valve implantation outcomes. |
| Q61400927 | Response by Valgimigli and Gargiulo to Letter Regarding Article, “A Critical Appraisal of Aspirin in Secondary Prevention: Is Less More?” |
| Q57764091 | Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization |
| Q30241829 | Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials |
| Q38636949 | State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation - past, present and future perspectives. |
| Q47570112 | Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results? |
| Q62590239 | Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, op |
| Q41767985 | Time for science to catch up with clinical practice? |
| Q49897223 | To EncourAGE Individualized Dual Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation: A New pAGE of an Intriguing Book |
| Q54031374 | Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement. |
| Q30249767 | Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement: A Systematic Review and Meta-analysis. |
| Q26780172 | Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients |
| Q51807764 | Unexpected preserved brain perfusion imaging despite severe and diffuse atherosclerosis of supra-aortic trunks. |
| Q38249105 | Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes |
| Q34485974 | Use of statins in lower extremity artery disease: a review |
| Q48026146 | Use of the Dual-Antiplatelet Therapy Score to Guide Treatment Duration After Percutaneous Coronary Intervention |
| Q57764200 | Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture |
| Q87834280 | [Antithrombotic therapy in patients undergoing transcatheter aortic valve implantation] |
Search more.